Evaluating Ketorolac for reducing symptoms after ureteral stent placement
Official title: A Prospective, Randomized, Pilot Study of Preoperative Anti-Inflammatory Therapy for Ureteral Stent Symptoms
Run by Washington University School of Medicine · NCT03638999 · Data updated 2026-11-12
This study is testing if giving a pain medication called Ketorolac before placing a ureteral stent can help reduce discomfort and inflammation for people with kidney stones.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 36 (estimated) |
| Sponsor | Washington University School of Medicine Academic / other |
| Locations | 1 site (St Louis, Missouri) |
| Status | Recruiting |
| Started | July 31, 2018 |
| Main results expected | October 2026 |
| Study ends | October 2027 |
| Registry record updated | December 22, 2025 |
| Trial ID | NCT03638999 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old with renal urolithiasis scheduled for ureteral stent placement.
✕Probably not a fit
Patients with chronic NSAID use, active urinary tract infections, or those requiring bilateral stone procedures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study aims to assess the effectiveness of pre-operative intravenous Ketorolac in reducing inflammatory responses and stent-related symptoms in patients undergoing ureteral stent placement due to kidney stones. Eligible participants will be randomly assigned to receive either Ketorolac or a saline control before their procedure. The study will also evaluate the feasibility of recruitment and assessment procedures, alongside measuring plasma inflammatory markers at various stages. Follow-up will include a post-operative check-in to monitor patient recovery and adherence to the protocol.
Why it matters
Potential benefit: If successful, this approach could significantly reduce post-operative discomfort and improve recovery for patients undergoing ureteral stent placement.
How similar studies have gone: While the use of Ketorolac in this specific context is novel, similar studies have shown promise in reducing inflammation and pain in other surgical settings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Over 18 years of age and willing and able to provide informed consent * Patients with renal urolithiasis planning to undergo ureteral stent placement following ureteroscopic manipulation Exclusion Criteria: * Patients requiring a bilateral stone procedure. * Patients on a chronic non-steroidal anti-inflammatory drugs (NSAIDs) including Aspirin defined as any NSAIDs use for more than fifteen days within thirty days prior to the procedure. Exception: use of daily Aspirin 81 mg is allowed. * Patients on any steroid therapy. * Patients with prescription anti-inflammatory drugs. * Patients with gastrointestinal ulcers. * Patients with ureteral obstruction or stricture unrelated to stone disease. * Patients with active urinary tract infection as evidence of untreated positive urine culture obtained prior to the procedure (as part of pre-operative testing). * Patients with preexisting indwelling ureteral stent * Patients who are pregnant or lactating. * Patients with renal or liver impairment. * Patients with concurrent disease, infection, or co-morbidity that, in the judgment of the investigator, would render the patient inappropriate for enrollment.
Where it's running
-
Washington University
St Louis, Missouri, United States Recruiting
Study contacts
- Principal investigator: Alana Desai, MD — Washington University School of Medicine
- Study coordinator: Alana Desai, MD
- Email: desaia@email.wustl.edu
- Phone: (314)
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Emergency urinary drainage followed by PCNL in obstructive urosepsis
Doctors test whether the method of emergency drainage (retrograde ureteral stent or percutaneous nephrostomy) affects how well patients do after undergoing definitive PCNL.
-
Observation vs Upfront Surgery for Asymptomatic Kidney Stones in Children and Adults
This trial tests whether watching asymptomatic kidney stones or performing upfront surgery is better for reducing life disruption in patients aged 6 and older.
-
Two-Tier Virtual Reality Education to Reduce Anxiety Before Kidney Stone Surgery
This study tests whether a two-tier VR preoperative education approach can lower anxiety and improve knowledge and self-care in adults undergoing urolithiasis surgery.
-
Tamsulosin 0.4 mg with Tadalafil 5 mg versus 2.5 mg to reduce symptoms from ureteral stents
This will test whether adding Tadalafil at 5 mg or 2.5 mg to Tamsulosin 0.4 mg better reduces stent-related symptoms for adults with a double-J ureteral stent after stone removal.
-
Ureteral access sheath: omitting versus placing a stent after ureteroscopy
We will test if leaving out a ureteral stent after ureteroscopy with an access sheath works as well as placing a stent for pre-stented adults with kidney or ureteral stones.
-
Using a flexible suction sheath with flexible ureteroscopy for lower-pole kidney stones
This trial will test whether adding a flexible, navigable suction sheath to flexible ureteroscopy helps adults with lower-pole kidney stones become stone-free more often and avoid repeat procedures.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.